| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.68B | -6.7% |
| R&D Expense | $45.0M | +55.2% |
| SG&A Expense | $2.55B | +14.9% |
| Operating Income | $2.05B | -36.1% |
| Interest Expense | $22.8M | +40.8% |
| Pre-tax Income | $3.10B | -3.5% |
| Income Tax | $731.7M | -4.1% |
| Net Income | $2.37B | -3.4% |
| EPS (Basic) | $4.34 | -5.0% |
| EPS (Diluted) | $3.61 | -4.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.79B | -26.5% |
| Short-term Investments | $836.0M | -71.9% |
| Accounts Receivable | $953.8M | +1.2% |
| Inventory | $502.4M | -6.1% |
| Current Assets | $4.61B | -38.7% |
| Total Assets | $52.61B | +9.6% |
| Current Liabilities | $6.02B | -7.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.09B | -23.3% |
| Capital Expenditures | $2.73B | +130.0% |
| Investing Cash Flow | -$8.79B | -99.2% |
| Financing Cash Flow | -$191.3M | -104.1% |
| Free Cash Flow | $364.8M | -87.2% |
| Total Liabilities |
| $34.20B |
| +6.6% |
| Stockholders' Equity | $17.94B | +15.6% |